We are experiencing an unusually high call volume. If you are unable to reach us by phone, submit your inquiry via email at customerservice.dpr@delaware.gov. Please read the important COVID-19 information from the Division of Professional Regulation. More Info

Delaware.gov logo
Division of
Professional Regulation

Controlled Substances



Objective and Function

The primary objective of the Controlled Substance Advisory Committee is to promote, preserve and protect the public health, safety and welfare by regulating and monitoring use and abuse of controlled substances. To meet this objective, the Committee:

  • carries out a program of registration, inspection, investigation and¬†education.
  • recommends new/revised rules and regulations and disciplinary sanctions against registrants to the Secretary of State.

The Committee issues registrations to practitioners and facilities that prescribe, dispense, manufacture or distribute controlled substances. Practitioners include physicians, physician assistants, advanced practice registered nurses, podiatrists, dentists, optometrists, and veterinarians. Facilities include pharmacies, distributors, manufacturers, hospitals, clinics, researchers, laboratories and provider pharmacies.

To assist the Committee, the Drug Control Administrator for the Division of Professional Regulation is responsible for the Committee’s regular administrative functions.

The Committee’s authority is in 16 Del. C., Chapter 47 and the Uniform Controlled Substance Act Regulations.


Meetings

Unless notified otherwise, the Committee meets every other month. All meetings are open to the general public. They are usually held in the Buena Vista Conference Center, 661 S. Dupont Hwy., Buck Library, 1st Floor, New Castle, DE 19720, but the location is subject to change. The meeting schedule is available at the State of Delaware public meeting calendar.

The Committee may need to review and approve your application for licensure and will only review a complete application. A complete application includes your application and any documentation submitted through DELPROS and/or any documents submitted through the mail or email from third-parties. The Committee will review your documentation at its next scheduled meeting.

 

Picture of the DPR stars icon

News

NEW RULES ON PRESCRIBING OPIATES: New regulations on prescribing opiates went into effect on April 1, 2017. The new rules:

  • establish basic standards for prescribing opiates safely
  • give new requirements on prescribing opiates for acute episodes as well as for chronic, long term pain management

To understand the new regulations and why they were developed, please see following materials:

NEW EDUCATION REQUIREMENTS FOR RENEWALS: For every renewal, you must complete two hours of continuing education (CE) in the areas of controlled substance prescribing practices, treatment of chronic pain, or other topics related to prescribing controlled substances. You will be required to attest to completing the required CE on your renewal application, and your registration will not renewed until you have completed the CE. See Section 3.1.3 of the Rules and Regulations.

 

Phone – Fax – Email
(302) 744-4500
(302) 739-2711
customerservice.dpr@delaware.gov
Mailing address:
Cannon Building,
Suite 203
861 Silver Lake Blvd.
Dover, DE 19904

Related Topics:  , , , , , , , , ,


+